Pneumococcal colonization among tracheostomy tube dependent children

PLoS One. 2018 Oct 19;13(10):e0206305. doi: 10.1371/journal.pone.0206305. eCollection 2018.

Abstract

Streptococcus pneumoniae colonization is a precursor to pneumococcal disease. Although children with a tracheostomy have an increased risk of pneumococcal pneumonia, the pneumococci colonizing their lower airways remain largely uncharacterized. We sought to compare lower respiratory tract isolates colonizing tracheostomy patients and a convenience sample of isolates from individuals intubated for acute conditions. We collected pneumococcal isolates from the lower respiratory tract of 27 patients with a tracheostomy and 42 patients intubated for acute conditions. We compared the penicillin susceptibility, rates of co-colonization, genetic background, and serotype of isolates colonizing these patient populations. Isolates from both groups showed high genetic diversity. Forty multi-locus sequence types and 20 serotypes were identified. There was no significant difference in serotype distribution, co-colonization rates, vaccine coverage, or non-susceptibility to penicillin among pneumococcal isolates from the two groups. Colonization of the lower airways with non-vaccine serotypes 15B/C, 23B and 35B was noted for the first time in patients with tracheostomies and supports recently observed increases in nasopharyngeal colonization and disease due to these serotypes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Child, Preschool
  • Drug Resistance, Bacterial
  • Female
  • Humans
  • Infant
  • Intubation, Intratracheal*
  • Male
  • Nasopharynx / microbiology
  • Penicillins / pharmacology
  • Penicillins / therapeutic use
  • Pneumococcal Vaccines / immunology
  • Pneumonia, Pneumococcal / drug therapy
  • Pneumonia, Pneumococcal / microbiology*
  • Pneumonia, Pneumococcal / prevention & control
  • Respiratory Insufficiency / therapy
  • Retrospective Studies
  • Serogroup
  • Streptococcus pneumoniae / drug effects
  • Streptococcus pneumoniae / isolation & purification*
  • Tracheostomy

Substances

  • Anti-Bacterial Agents
  • Penicillins
  • Pneumococcal Vaccines

Grants and funding

This study was supported by an Infectious Disease Consortium award from Nationwide Children’s Hospital to G.E. and S.J.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Nationwide Children’s Hospital.